Form 4: ANI Pharmaceuticals Director Acquires Shares Through Restricted Stock Award

Director Antonio R. Pera acquired 4,410 shares of ANI Pharmaceuticals common stock through a restricted stock award that will vest on May 21, 2025.

Summary

• On May 21, 2024, Antonio R. Pera, a director of ANI Pharmaceuticals, acquired 4,410 shares of common stock.
• The acquisition was a result of a restricted stock award.
• The shares were acquired at a price of $0.
• Following the transaction, Pera directly owns 31,037 shares of ANI Pharmaceuticals.
• The restricted stock award will vest in full on May 21, 2025.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of a stock transaction. The director's acquisition could be seen as a positive signal, but it's not a major event.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future prospects.

Future Outlook

The restricted stock award will vest in full on May 21, 2025.

Industry Context

This filing is a routine disclosure of a transaction by a company insider, which is common in the pharmaceutical industry.

Stakeholder Impact

• The acquisition of shares by a director could have a slightly positive impact on shareholder sentiment.

Key Dates